Profusa, Inc. Common Stock (PFSA) is a Healthcare · Medical Devices company listed on NASDAQ. Price $1.94 (+7.78%), Market cap $0.00B, 52-week low–high $0.06 ~ $3.16.
Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Financial statements, price targets, institutional (13F) holdings and related news for Profusa, Inc. Common Stock are updated in real time on BlackAll Trade.
Profusa, Inc. Common Stock trades at $1.94 (+7.78%). Real-time quotes and charts are available on BlackAll Trade.
Profusa, Inc. Common Stock has a market cap of about $0.00B.
Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to